Select Page
The Word Lab
Keeping industry professionals up-to-date with the latest news affecting life science translations
All Posts
Topic

Regulatory


NDA Submitted by Antengene in South Korea

NDA Submitted by Antengene in South Korea

Antengene submitted yesterday (1/3) a New Drug Application (NDA) with Orphan Drug Designation (ODD) to South Korea’s regulatory body, the Ministry of Food and Drug Safety (MFDS), for ATG-010 (selinexor). The NDA is specifically for the approval of ATG-010 (selinexor)...